Literature DB >> 11514132

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

G Donohoe1, N Owens, C O'Donnell, T Burke, L Moore, A Tobin, E O'Callaghan.   

Abstract

OBJECTIVE: To identify clinically useful predictors of adherence to medication among persons with schizophrenia.
METHOD: We evaluated levels of compliance with neuroleptic medication among 32 consecutive admissions with DSM-III-R schizophrenia from a geographically defined catchment area using a compliance interview. We also assessed symptomatology, insight, neurological status and memory.
RESULTS: Less than 25% of consecutive admissions reported being fully compliant. Drug attitudes were the best predictor of regular compliance, symptomatology the best predictor of noncompliance, and memory the best predictor of partial compliance with neuroleptic medication.
CONCLUSIONS: These data emphasise the complexity of factors that influence whether a person adheres to his medication regimen. Furthermore, they suggest that these factors may vary within the same person over time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514132     DOI: 10.1016/s0924-9338(01)00581-8

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  23 in total

Review 1.  Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review.

Authors:  Tania M Lincoln; Eva Lüllmann; Winfried Rief
Journal:  Schizophr Bull       Date:  2007-02-08       Impact factor: 9.306

2.  Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment.

Authors:  Kun-Po Chen; For-Wey Lung
Journal:  Psychiatr Q       Date:  2017-12

3.  Religious beliefs in schizophrenia: their relevance for adherence to treatment.

Authors:  L Borras; S Mohr; P-Y Brandt; C Gilliéron; A Eytan; P Huguelet
Journal:  Schizophr Bull       Date:  2007-01-09       Impact factor: 9.306

4.  Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.

Authors:  Kenneth L Subotnik; Keith H Nuechterlein; Joseph Ventura; Michael J Gitlin; Stephen Marder; Jim Mintz; Gerhard S Hellemann; Leslie A Thornton; Indira R Singh
Journal:  Am J Psychiatry       Date:  2011-01-04       Impact factor: 18.112

5.  Impact of depression and social support on nonadherence to antipsychotic drugs in persons with schizophrenia in Thailand.

Authors:  Sirijit Suttajit; Sutrak Pilakanta
Journal:  Patient Prefer Adherence       Date:  2010-10-05       Impact factor: 2.711

6.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia.

Authors:  Somaia Mohamed; Robert Rosenheck; Joseph McEvoy; Marvin Swartz; Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Bull       Date:  2008-06-26       Impact factor: 9.306

7.  Taking the perspective of the other contributes to awareness of illness in schizophrenia.

Authors:  Robyn Langdon; Philip Ward
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

8.  Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats.

Authors:  A V Terry; D A Gearhart; S Warner; E J Hohnadel; M-L Middlemore; G Zhang; M G Bartlett; S P Mahadik
Journal:  Neuroscience       Date:  2007-09-14       Impact factor: 3.590

9.  Adolescent attitudes toward psychiatric medication: the utility of the Drug Attitude Inventory.

Authors:  Lisa Townsend; Jerry Floersch; Robert L Findling
Journal:  J Child Psychol Psychiatry       Date:  2009-07-21       Impact factor: 8.982

10.  Outpatient antipsychotic treatment and inpatient costs of schizophrenia.

Authors:  Steven C Marcus; Mark Olfson
Journal:  Schizophr Bull       Date:  2007-06-19       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.